Entry |
|
Name |
Prinomastat (USAN/INN) |
Formula |
C18H21N3O5S2
|
Exact mass |
423.0923
|
Mol weight |
423.51
|
Structure |

|
Efficacy |
Antineoplastic, Angiogenesis inhibitor, Matrix metalloproteinase inhibitor |
Comment |
Treatment for retinal and subfoveal choroidal neovascularization
|
Target |
|
Pathway |
hsa04670 | Leukocyte transendothelial migration |
|
Brite |
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Metallo peptidases
Family M10
MMP2
D03797 Prinomastat (USAN/INN)
MMP3
D03797 Prinomastat (USAN/INN)
MMP9
D03797 Prinomastat (USAN/INN)
MMP13
D03797 Prinomastat (USAN/INN)
MMP14
D03797 Prinomastat (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 O1b O 15.1424 -17.1500
2 N1b N 16.3549 -17.8500
3 C5a C 17.5673 -17.1500
4 C1y C 18.7797 -17.8500
5 O5a O 17.5673 -15.7500
6 N1y N 20.1797 -17.8500
7 C1z C 18.0797 -19.0624
8 S2x S 18.7797 -20.2749
9 C1x C 20.1797 -20.2749
10 C1x C 20.8797 -19.0624
11 S4a S 21.3724 -17.1500
12 C8y C 22.5849 -17.8500
13 O3c O 22.3624 -16.1601
14 O3c O 20.3825 -16.1601
15 C8x C 22.5849 -19.2498
16 C8x C 23.7973 -19.9498
17 C8y C 25.0097 -19.2498
18 C8x C 25.0097 -17.8500
19 C8x C 23.7973 -17.1500
20 O2a O 26.2074 -19.9414
21 C8y C 27.3955 -19.2554
22 C8x C 28.5864 -19.9431
23 C8x C 29.7989 -19.2432
24 N5x N 29.7990 -17.8432
25 C8x C 28.6082 -17.1555
26 C8x C 27.3957 -17.8554
27 C1a C 16.6797 -19.0624
28 C1a C 17.3797 -20.2749
BOND 30
1 1 2 1
2 2 3 1
3 4 3 1 #Down
4 3 5 2
5 4 6 1
6 4 7 1
7 7 8 1
8 8 9 1
9 9 10 1
10 6 10 1
11 6 11 1
12 11 12 1
13 11 13 2
14 11 14 2
15 12 15 2
16 15 16 1
17 16 17 2
18 17 18 1
19 18 19 2
20 12 19 1
21 17 20 1
22 20 21 1
23 21 22 2
24 22 23 1
25 23 24 2
26 24 25 1
27 25 26 2
28 21 26 1
29 7 27 1
30 7 28 1
|